Jan 25, 2025, 05:02
HER2DX in HER2+ Inflammatory Breast Cancer: Correlative insights and comparative analysis
Dana-Farber’s Breast Oncology Center shared a post on X about a recent paper by F. Lynce et al. published in ESMO Open:
“Just Published in ESMO Open: HER2DX in HER2-positive Inflammatory Breast Cancer: Correlative insights and comparative analysis with noninflammatory Breast Cancers.”
Authors: F Lynce, O Martínez-Sáez, B Walbaum, A Prat, S M Tolaney et al.
More posts featuring Dana-Farber’s Breast Oncology Center.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 21:04
Apr 19, 2025, 20:48
Apr 19, 2025, 20:25
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17
Apr 19, 2025, 19:01
Apr 19, 2025, 18:42
Apr 19, 2025, 18:29